GlassScriptPhysician profile
Lloyd I Maliner
NPI 1255336863
$2,480.99
in general payments reported to CMS, 2019-2025
15 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $633 · 2020: $156 · 2021: $359 · 2022: $686 · 2023: $326 · 2024: $198 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $646.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $613.43 | 2019-2023 | Senza |
| Medtronic, INC. | $552.13 | 2022-2024 | Intellis Adaptivestim |
| Spineology INC. | $444.31 | 2019-2021 | |
| Si-Bone, INC. | $228.02 | 2019 | |
| Stryker Corporation | $217.06 | 2019-2025 | Mako |
| Abbott Laboratories | $148.72 | 2023 | Proclaim |
| Nuvasive, INC. | $56.74 | 2020 | |
| Nalu Medical, INC. | $44.80 | 2021 | |
| Portola Pharmaceuticals, LLC | $33.10 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.21 | 2022 | |
| Cerapedics INC. | $31.24 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Spinal Elements, INC. | $27.40 | 2024 | |
| Globus Medical, INC. | $19.83 | 2025 | Senza |
| Janssen Biotech, INC. | $16.40 | 2021 | |
| Depuy Synthes Sales INC. | $15.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lloyd Maliner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.